Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.30 -0.09 (-6.47%)
At close: Oct 1, 2026 · 4:00 PM EDT

Alx Oncology Holdings (ALXO) Capital Expenditures (2019 - 2026)

Updated

Alx Oncology Holdings (ALXO) posted Capital Expenditures of $17,000 for Q2 2026, down 63.8% from $47,000 a year earlier and down 66.0% from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Capital Expenditures (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Alx Oncology Holdings was $172,000, down 45.6% year-over-year; for FY2025, it came in at $212,000, down 52.6% from FY2024.

  • Annual Capital Expenditures has declined for three consecutive years, though with a five-year compound annual growth rate of 46.9% (FY2020 to FY2025).
  • In prior years, Alx Oncology Holdings' Capital Expenditures was $447,000 in FY2024 (-64.9%), $1.27 million in FY2023 (-10.7%), $1.43 million in FY2022 (+114.3%) and $666,000 in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Capital Expenditures since Q3 2023.
  • On a year-over-year basis, Capital Expenditures has declined in each of the last seven quarters, with an average decline of 46.8% over the last seven quarters.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2023, with growth of 576.7%; the weakest was Q2 2024, with a decline of 94.8%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $50,000 (Q1 2026), $49,000 (Q4 2025) and $56,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Alx Oncology Holdings 192.12 Mn 192.12 Mn - 17,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17,000.00
Mar 31, 2026 50,000.00
Dec 31, 2025 49,000.00
Sep 30, 2025 56,000.00
Jun 30, 2025 47,000.00
Mar 31, 2025 60,000.00
Dec 31, 2024 60,000.00
Sep 30, 2024 149,000.00
Jun 30, 2024 90,000.00
Mar 31, 2024 148,000.00
Dec 31, 2023 148,000.00
Sep 30, 2023 -1.30 Mn
Jun 30, 2023 1.74 Mn
Mar 31, 2023 690,000.00
Dec 31, 2022 389,000.00
Sep 30, 2022 192,000.00
Jun 30, 2022 257,000.00
Mar 31, 2022 589,000.00
Dec 31, 2021 261,000.00
Sep 30, 2021 398,000.00
API Access

Alx Oncology Holdings Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ALXO&period=max&api_key=YOUR_API_KEY